SCHEMBL23048583

SCHEMBL23048583

CN1CCC(Sc2cc(C=O)ccn2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ WNT1 P04628 4/20 0.41
▸ GSK3B P49841 4/20 0.41
▸ DYRK1A Q13627 4/20 0.41
▸ ALDH1A1 P00352 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ KDM2B Q8NHM5 2/20 0.33
▸ HRH4 Q9H3N8 1/20 0.33
▸ HCRTR2 O43614 3/20 0.32
▸ MAPKAPK2 P49137 1/20 0.32
▸ BRD4 O60885 1/20 0.32
▸ ATAD2 Q6PL18 1/20 0.32
▸ KEAP1 Q14145 1/20 0.32
▸ NFE2L2 Q16236 1/20 0.32
▸ LRRK2 Q5S007 1/20 0.32
▸ DRD2 P14416 1/20 0.32
▸ DRD1 P21728 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19546938 0.86 WNT1 (0.39) WNT1GSK3BDYRK1AMEN1GAA
SCHEMBL23048639 0.84 WNT1 (0.38) WNT1GSK3BDYRK1AKDM2BHRH4
SCHEMBL20951081 0.77 KDM2B (0.54) WNT1GSK3BDYRK1AALDH1A1MAPT
SCHEMBL8302529 0.73 EHMT2 (0.42) WNT1GSK3BDYRK1AALDH1A1MEN1
SCHEMBL20951194 0.72 WNT1 (0.49) WNT1GSK3BDYRK1AKMT2AKDM2B
SCHEMBL23048776 0.71 WNT1 (0.42) WNT1GSK3BDYRK1AALDH1A1MEN1
SCHEMBL28531937 0.70 ALDH1A1 (0.42) ALDH1A1MAPTHPGD
SCHEMBL19547056 0.69 HRH4 (0.55) ALDH1A1MEN1GAAKMT2AHRH4
SCHEMBL16293110 0.69 KDM2B (0.38) GSK3BKDM2B
SCHEMBL8302411 0.68 TLR9 (0.37) WNT1GSK3BDYRK1AGAAKDM2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3448386-B1 ISOQUINOLIN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF SAMUMED LLC (US) 2021-03-03 — — EP disclosed
Send feedback